Taigle becomes SAFE-BioPharma partner

Thursday, October 20, 2011 01:21 PM

Taigle has become a vendor partner of SAFE-BioPharma, the non-profit that manages the SAFE-BioPharma digital identity and signature standard for the biopharmaceutical and healthcare industries. The SAFE-BioPharma standard allows its member companies to meet security and confidentiality needs specific to the life sciences.

Taigle provides seamless and fully integrated software solutions to companies in the healthcare, financial services, media and entertainment, and other industries. The company’s MySignatureBook service, which allows people with interoperable digital identities to access and apply digital signatures to documents in the cloud, is being used by the National Cancer Institute, Bristol-Myers Squibb, and Sanofi-Aventis in their cloud-based research collaboration.  

SAFE-BioPharma digital identities are interoperable with US government regulatory and other agencies and with other organizations across the life sciences and other industries.

“As a SAFE-BioPharma vendor partner we will be closer to the growing global community of companies and other organizations that use the standard to improve their operations,” said Ajit Sodhi, president, Taigle. “We are committed to helping members verify and manage digital identities and to apply SAFE-BioPharma digital signatures.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs